What We're Reading: Page 9
Industry reads hand-picked by our editors
Mar 05, 2026
-
The New York Times
F.D.A. Faces Upset Over Denials of New Drugs
-
BioCentury
Bourla comments add to cloud over Prasad
-
Nature
Cancer blood tests are everywhere. Do they really work?
Mar 04, 2026
Mar 03, 2026
Mar 02, 2026
-
The Guardian
As measles spreads in South Carolina, RFK Jr’s allies work to gut vaccine laws
-
Reuters
Hims expansion may not come in time for risky GLP-1 business
-
The Financial Times
A year on a cancer vaccine trial at London’s oldest hospital
-
Axios
Why new doctors aren’t specializing in infectious diseases
Feb 27, 2026
Feb 26, 2026
-
CNBC
FDA Commissioner Dr. Makary on rare disease therapy approvals, internal politics at the agency
-
CNN
Takeaways from surgeon general nominee Casey Means’ Senate confirmation hearing
-
STAT
A rare disease drug was approvable, then it wasn’t. Inside a surprise rejection by the FDA
-
The Financial Times
The elusive grail of blood tests that spot cancer early
Feb 25, 2026
-
The Wall Street Journal
Who’s in Charge at the FDA?
-
Axios
Trump touts drug price cuts most Americans may not feel
-
KFF Health News
Hospitals Fighting Measles Confront a Challenge: Few Doctors Have Seen It Before
Previous
